James C. Katzaroff - May 12, 2021 Form 4/A - Amendment Insider Report for GlobeStar Therapeutics Corp (GSTC)

Role
CEO, Director
Signature
James C. Katzaroff
Stock symbol
GSTC
Transactions as of
May 12, 2021
Transactions value $
$50,000
Form type
4/A - Amendment
Date filed
4/4/2023, 11:24 AM
Date Of Original Report
Apr 3, 2023
Next filing
Aug 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GSTC Common stock Other $50K +7.04M +70.42% $0.01 17M Apr 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GSTC Options Award $0 +30M $0.00 30M May 12, 2021 Common stock 30M $0.03 Direct
transaction GSTC Options Award $0 +35M +116.67% $0.00 65M Feb 24, 2023 Common stock 35M $0.01 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to conversion of debt of $50,000.
F2 Options vest 50% when granted and balance ratably on a daily basis during the 24 month period commencing on date of grant.
F3 Vested Options are exercisable 6 months after date of grant and thereafter until 5 years after the date of grant.

Remarks:

This Form 4/A Amendment No. 1 is being filed to correct a typographical error in Table I, box 4 on the original Form 4 filing. The shares acquired pursuant to conversion of debt of $50,000 has been corrected from 70,422,535 to 7,042,253.